Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Click here to register

Clinical Pediatrics
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by MacArthur, C. J.
Right arrow Articles by Healy, G. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by MacArthur, C. J.
Right arrow Articles by Healy, G. B.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Pediatric Head and Neck Rhabdomyosarcoma

Carol J. MacArthur, M.D.

From The 300 Longwood Avenue, The Children's Hospital, Boston, MA 02115

Trevor J.I. McGill, M.D.

From The Children's Hospital, Boston, Massachusetts

Gerald B. Healy, M.D.

From The Children's Hospital, Boston, Massachusetts

Rhabdomyosarcoma (RMS), the most common malignant soft-tissue tumor in the pediatric population, occurs most often in the head and neck region. Major advancements in the management of these aggressive tumors have been achieved in the last 20 years on three fronts: chemotherapy, radiation therapy, and surgery. Surgery, with the advent of skull-base, craniofacial, and free-tissue-transfer reconstructive techniques, has once again become part of the primary management of these tumors. Prior to 1960, RMS was uniformly fatal; now, with the introduction of multimodality treatment regimens, two thirds of patients can expect long-term survival.

Clinical Pediatrics, Vol. 31, No. 2, 66-70 (1992)
DOI: 10.1177/000992289203100201
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Vet PatholHome page
I.-H Bae, Y. Kim, B. Pakhrin, M.-H You, C.-Y Hwang, J.-H Kim, and D.-Y Kim
Genitourinary Rhabdomyosarcoma with Systemic Metastasis in a Young Dog
Vet. Pathol., July 1, 2007; 44(4): 518 - 520.
[Abstract] [Full Text] [PDF]